Hand-foot-skin reaction of grade ≥ 2 within sixty days as the optimal clinical marker best help predict survival in sorafenib therapy for HCC.
Wang E, Xia D, Bai W, Wang Z, Wang Q, Liu L, Wang W, Yuan J, Li X, Chen H, Lv Y, Niu J, He C, Guo W, Yin Z, Luo B, Han N, Wang Z, Yu T, Yuan X, Li K, Tie J, Li C, Cai H, Xia J, Fan D, Han G.
Wang E, et al. Among authors: li c, li x, li k.
Invest New Drugs. 2019 Jun;37(3):401-414. doi: 10.1007/s10637-018-0640-7. Epub 2018 Jul 18.
Invest New Drugs. 2019.
PMID: 30019101